POST-COVID SYNDROME. PATHOGENESIS AND CLINICAL MANIFESTATIONS (PART 1)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper reviews the results of foreign and Russian investigations of the clinical and pathogenetic features of longterm andpost-COVID syndrome in in- and outpatients with COVID-19.

Full Text

Restricted Access

About the authors

Khadizhat G. Omarova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: omarova71@inbox.ru
Head, Clinical Research Department Moscow, Russia

Vera V. Makashova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: veramakashova@yandex.ru
MD, Leading Researcher Moscow, Russia

Zhanna B. Ponezheva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: doktorim@mail.ru
MD, Head, Clinical Department of Infectious Pathology Moscow, Russia

Akxey V. Ageykin

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ageykinav@yandex.ru
Junior Researcher, Clinical Department ofInfectious Pathology Moscow, Russia

Darya M. Mitenkova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: mitenkova.dasha@yandex.ru
Resident Moscow, Russia

Antonina A. Ploskireva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: antonina@ploskireva.com
MD, Deputy Director for Clinical Services Moscow, Russia

References

  1. https://yandex.ru/covid19/stat?win=536
  2. Li X., Ma X. Acute respiratory failure in COVID-19: is it «typical» ARDS. Crit. Care 2020; 24(1): 198. DOI: 10.1186/ s13054-020-02911-9.
  3. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188. Published date:18 December 2020]. NICE
  4. WHO European Regional Technical Briefing. Rehabilitation after COVID-19: what we know and what resources we have. Virtual meeting organized by the WHO Regional Office for Europe. Copenhagen: WHO Regional Office for Europe; 2022. License: CC BY-NCSA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/351043/WHO-EURO-2022-3995-43754-62897-rus.pdf?sequence=1&isAllowed=y
  5. Benjamin Davido, Sophie Seang, Roland Tubiana, Pierre de Truchis. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin. Microbiol, Infect. 2020 Nov;26(11):1448-1449. doi: 0.1016/j.cmi.2020.07.028
  6. Рекомендации по ведению больных с коронавирусной инфекцией COVID-19 в острой фазе и при постковидном синдроме в амбулаторных условиях. https://guidelines.mgnot.ru/v2_2021
  7. FLCCC Alliance - COVID-19 Management Protocol, 02-222022, Version 68. https://covid19criticalcare.com/wp-content/uploads/2020/12/FLCCC-Protocols-E28093-A-Guide-to-the - Management- of- COVI D-19.pdf
  8. Love S., Chalmers K., Ince P., Esiri M, Attems J., Jellinger K. et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am. J. Neurodegener. Dis. 2014; 3(1): 19-32.
  9. Kehoe P.G., Wong S., Mulhim N.A.L., Palmer L.E., Miners J.S. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-beta and tau pathology. Alzheimers Res. Ther. 2016; 8(1): 50. doi: 10.1186/s13195-016-0217-7
  10. Kuo C.L., Pilling L.C., Atkins J.L., Masoli J.A.H., Delgado J., Kuchel G.A. et al. APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort. J. Gerontol. A Biol. Sci. Med. Sci. 2020; 75(11): 2231-2. doi: 10.1093/gerona/glaa131
  11. Futtrup J., Margolinsky R., Benros M.E., Moos T., Routhe L.J., Rungby J. et al. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in casecontrol studies. Brain Behav Immun. Health 2020; 90: 364-80. doi: 10.1016/j.bbi.2020.08.028
  12. Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimer’s Res. Ther. 2020; 12(1): 170. doi: 10.1186/s13195-020-00744-w
  13. Naughton S.X., Raval U., Pasinetti G.M. Potential Novel Role of COVID-19 in Alzheimer’s disease and preventative mitigation strategies. J. Alzheimers Dis. 2020; 76(1): 21-5. doi: 10.3233/JAD-200537
  14. Pinna P., Grewal P., Hall J.P., Tavarez T., Dafer R.M., Carg R. et al. Neurological manifestations and COVID-19: experiences from a tertiary care center at the frontline. J. Neurol.Sci. 2020; 415: 116969. doi: 10.1016/j.jns.2020.116969
  15. Magoon R. Pulmonary vasculature in COVID-19: mechanism to monitoring! Korean. J. Anesthesiol. 2021; 74(2): 186-7. doi: 10.4097/kja.20536
  16. Carfi A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA 2020; 324(6): 603-5. doi: 10.1001/jama.2020.12603
  17. Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C. et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network -United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993-8. doi: 10.15585/mmwr.mm6930e1
  18. Van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H. et al.Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19). Clin. Infect. Dis. 2021; 73(5): e1089-98. DOI: 10.109 3/cid /ciaa 1750
  19. Хасанова Д.Р., Житкова Ю.В., Васкаева Г.Р. Постковидный синдром: обзор знаний о патогенезе, нейропсихиатрических проявлениях и перспективах лечения. Неврология, нейропсихиатрия, психосоматика 2021; 13(3): 93-8. doi: 10.14412/2074-2711- 2021-3-93-98
  20. Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021; 9(2): 129. doi: 10.1016/S2213-2600(21)00031-X

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies